A Phase II Single Arm Clinical Trial Assessing the Efficacy and Safety of BIntrafusp Alfa (M7824) in Previously Treated Advanced Malignant Pleural MESothelioma (BIMES)
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Bintrafusp alfa (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- Acronyms BIMES
- 19 Sep 2024 Status changed from recruiting to completed.
- 04 Jun 2024 Results (n=47) assessing efficacy and safety of bintrafusp alfa in previously treated advanced malignant pleural mesothelioma were presented at the 60th Annual Meeting of the American Society of Clinical Oncology.
- 02 Sep 2021 Status changed from not yet recruiting to recruiting.